Dr. Charles Vainder, MD

Dr. Vainder practices at USC Verdugo Hills Ambulatory Surgery Center in Glendale, California.

Dr. Vainder's NPI, 1700296829, was assigned on April 28, 2014. Dr. Vainder graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014. Dr. Vainder holds California license A168465.

Dr. Vainder's primary practice is USC Verdugo Hills Ambulatory Surgery Center, at 1818 Verdugo Blvd Ste B1, Glendale, CA 91208. The practice phone is (213) 740-7922.

Dr. Vainder's primary practice is USC Verdugo Hills Ambulatory Surgery Center in Glendale, California. The medical group on file is Skin & Beauty Center (SBC Dermatology). Dmand AI also links Dr. Vainder to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vainder practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Vainder's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Vainder is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Vainder's licenses on file in 3 states: California, Illinois and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Vainder treats.

CMS data shows 5,196 Medicare services from Dr. Vainder across 17 procedure codes in 2024, for 690 Medicare patients. Medicare paid $220,688 for them. Every service was in an office.

CMS counts 690 Medicare patients who saw Dr. Vainder in 2024. The largest group is 65 to 74, with 353 patients. 74% of them have high cholesterol, and 64% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vainder's median patient age at 55, with 54% women.

In 2024, Dr. Vainder wrote 1,205 Medicare Part D claims for 477 patients. 93% of them were for generic drugs. CMS names the drug for 1,126 of them, across 17 drugs with 11 or more claims each, at $182,248 in total drug cost. In 2023, CMS named 905 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Vainder for performance year 2024, reported as part of a group. Dr. Vainder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,136 procedures of removal of skin lesions by Dr. Vainder, more than 94% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Vainder in 2016. Dr. Vainder's most frequent co-author is Oleg E. Akilov, MD, PhD.

CMS Open Payments shows 455 general payments to Dr. Vainder from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,462.

Dr. Vainder graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2014.

Dr. Vainder is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.